UPDATE: Oppenheimer Raises Price Target On Curis On Aurigene Collaboration
January 22, 2015 at 09:45 AM EST
In a report published Thursday, Oppenheimer analyst Christopher Marai reiterated an Outperform rating on Curis, Inc. (NASDAQ: CRIS), and ...